Arcadia Biosciences Inc

NASDAQ RKDA

Data sourced from

and

Daily

Download Data

Arcadia Biosciences Inc Market Capitalization on June 03, 2024: USD 3.92 M

Arcadia Biosciences Inc Market Capitalization is USD 3.92 M on June 03, 2024, a -26.60% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.

Arcadia Biosciences Inc 52-week high Market Capitalization is USD 6.03 M on July 21, 2023, which is 53.61% above the current Market Capitalization.
Arcadia Biosciences Inc 52-week low Market Capitalization is USD 2.50 M on March 22, 2024, which is -36.35% below the current Market Capitalization.
Arcadia Biosciences Inc average Market Capitalization for the last 52 weeks is USD 3.64 M.

NASDAQ: RKDA

Arcadia Biosciences Inc

CEO	Ms. Pamela Haley
IPO Date	May 15, 2015
Location	United States
Headquarters	202 Cousteau Place, Davis, CA, United States, 95618
Employees	21
Sector	Consumer Defensive
Industry	Packaged foods

Description

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Key trends